Sanofi (SNY) Free Cash Flow (2019 - 2026)
Sanofi's Free Cash Flow history spans 10 years, with the latest figure at $2.0 billion for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 10.5% to $2.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $23.4 billion, a 15.29% increase, with the full-year FY2025 number at $8.4 billion, up 33.47% from a year prior.
- Free Cash Flow hit $2.0 billion in Q1 2026 for Sanofi, down from $11.2 billion in the prior quarter.
- Over the last five years, Free Cash Flow for SNY hit a ceiling of $12.0 billion in Q4 2023 and a floor of -$495.4 million in Q2 2024.
- Historically, Free Cash Flow has averaged $5.2 billion across 5 years, with a median of $3.1 billion in 2022.
- Biggest five-year swings in Free Cash Flow: plummeted 155.68% in 2024 and later soared 434.08% in 2025.
- Tracing SNY's Free Cash Flow over 5 years: stood at $11.2 billion in 2022, then grew by 6.9% to $12.0 billion in 2023, then decreased by 12.22% to $10.5 billion in 2024, then grew by 6.97% to $11.2 billion in 2025, then crashed by 82.47% to $2.0 billion in 2026.
- Business Quant data shows Free Cash Flow for SNY at $2.0 billion in Q1 2026, $11.2 billion in Q4 2025, and $8.5 billion in Q3 2025.